---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-025238"
form_type: "8-K"
ticker: "WGRX"
cik: "0002030763"
company_name: "Wellgistics Health, Inc."
filed_at: "2025-08-22T23:59:59+00:00"
generated_at: "2026-05-17T10:41:49.800219+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "medium"
source: SEC EDGAR
---

# Wellgistics Health Q2 2025 results: H1 pro forma revenue $18.65M, debt conversion strengthens balance sheet

## Summary
- Pro forma revenue for H1 2025 was $18.65M, up 2.2% from $18.25M in H1 2024.
- Converted $10.1M of debt into common stock equity (including $8.6M after June 30) to improve balance sheet flexibility.
- Completed operational integration of Wellgistics LLC and Wood Sage LLC, reduced SG&A, upgraded ERP system.
- Appointed UHY LLP, a PCAOB-registered auditor, which completed Q2 review; advancing SOC 2 certification.
- Expanding DTP programs in diabetes, weight loss, chronic pain; network includes 6,500+ pharmacies and 200 manufacturers.

## SEC filing metadata
- accession: 0001641172-25-025238
- form_type: 8-K
- ticker: WGRX
- cik: 0002030763
- company_name: Wellgistics Health, Inc.
- filed_at: 2025-08-22T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: medium
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/2030763/000164117225025238/0001641172-25-025238-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/2030763/000164117225025238/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-025238
- JSON: https://secwatch.observer/filing/0001641172-25-025238.json
- Plain text: https://secwatch.observer/filing/0001641172-25-025238.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.
